Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities

Similar documents
TRIPS and Access to Medicines. WR Briefing

TRIPS Article 27 Patentable Subject Matter

INTRODUCTION TO PATENT, UTILITY MODEL AND INDUSTRIAL DESIGN

International Patent Regime. Michael Blakeney

Topic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs

IP Strategies to Enhance Competitiveness: India s Experience

Intellectual Property

Presented at GIZ/SAWTEE Training on IPR 1-2 March 2012, Laltipur. Ratnakar Adhikari South Asia Watch on Trade, Economics and Environment

Regional Seminar on the Effective Implementation and Use of Several Patent-Related Flexibilities

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS

TRIPS Agreement and its Impact on Health

Standing Committee on the Law of Patents Twenty-Sixth Session

Chapter 5 The Fundamentals of the Patent System

Finland Russia Ukraine CONTENTS

PATENTABLE AND NON- PATENTABLE INVENTIONS R. MURALIDHARAN

TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities

1. TRIPS, intellectual property rights and access to medicines a,b

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

Brazilian Patent Substantive Examination

AN OVERVIEW OF THE UNITED STATES PATENT SYSTEM

TRIPs & PATENTS. In 1899, Mr. Charles H. Duell, Director of US Patent office said Everything that can be invented, has (already) been invented.

CS 4984 Software Patents

Ethiopia s Accession to World Trade Organization (WTO): The Need to Reform Ethiopian Patent Law to Facilitate Access to Medicine PART I

Intellectual Property and Genetic Resources: Relationship with Relevant International Instruments

Dr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board

The TRIPS Agreement and Patentability Criteria

19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights

PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS

Fall National SBIR/STTR Conference

Flexibilities in the Patent System

TRIPS Post Grant Flexibilities: Key Exceptions to Patent Holders' Rights. David Vivas Eugui

Protecting Your Innovations and IP. Dr. Matthias Nobbe German and European Patent Attorney European Trademark and Design Attorney

TRIPS FLEXIBILITIES AND ACCESS TO MEDICINES

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

Carnegie Endowment for International Peace

PATENT AND UTILITY MODELS

FÉDÉRATION INTERNATIONALE DES CONSEILS EN PROPRIÉTÉ INDUSTRIELLE. 24 February 2011 Via electronic filing

Questionnaire February 2010

Geneva, November 10-14, Topic 2: Patents

International IP. Prof. Eric E. Johnson. General Principles

Standing Committee on the Law of Patents

An overview of India's approach to key IP issues at home and abroad. Dr. Bona Muzaka King s College London

A POLICY in REGARDS to INTELLECTUAL PROPERTY. OCTOBER UNIVERSITY for MODERN SCIENCES and ARTS (MSA)

China: Managing the IP Lifecycle 2018/2019

TRIPS and Access to Medicines. The Story so far

PROTECTING INVENTIONS: THE ROLE OF PATENTS, UTILITY MODELS AND DESIGNS

Flexibilities in the Patent System

PUBLISH AND YOUR PATENT RIGHTS MAY PERISH ALAN M. EHRLICH WEISS, MOY & HARRIS, P.C.

Intellectual Property

Statement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL PROPERTY PROTECTION ON INNOVATION AND TECHNOLOGY DEVELOPMENT

Patent Working Requirements Historical and Comparative Perspectives

Topic 3 - Chapter II.B Primary consideration before drafting a patent application. Emmanuel E. Jelsch European Patent Attorney

Standing Committee on the Law of Patents

WTO NEGOTIATIONS ON TRIPS AND PUBLIC HEALTH: AN OVERVIEW. Jayashree Watal WTO Secretariat

Nitya Nanda. The Energy and Resources Institute (TERI)

Standing Committee on the Law of Patents

PREP Course 32: Intellectual Property (IP) in Research Kirk R. Manogue, PhD Vice President, Technology Transfer

INTRODUCTION TO THE ARIPO PATENT SYSTEM AND PROCEDURES

Intellectual Property and Public Health - International Framework and Recent Developments in WIPO: SCP and CDIP

Chapter 15: Access to essential medicines, TRIPS and the patent system

Intellectual Property Overview

Practical Strategies for Biotechnology and Medical Device Companies to Manage Intellectual Property Rights

Virtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12:

Te Hunga Roia Maori o Aotearoa (Maori Law Society Inc.)

5/30/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

Intellectual Property Importance

Protection of New Plant Varieties under the TRIPS Agreement

Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy

LAW ON TECHNOLOGY TRANSFER 1998

Lecture 42 Scientific Knowledge in India: From Public Resource to Intellectual Property

Enforcement Regulations of the Pharmaceutical Affairs Law

The TRIPS Tightrope public health, innovation, incentives and access

Exhaustive Training module for new Patent examiners

372 index. predominantly for supply of domestic market 113, 132 3, 184 5, 186; remedying anticompetitive

Technology Transfer and Intellectual Property Best Practices

Leveraging Intellectual Property for Success

Introduction to IP: Some Basics of Patents, Trademarks, & Trade Secrets

Invention SUBMISSION BROCHURE PLEASE READ THE FOLLOWING BEFORE SUBMITTING YOUR INVENTION

Judicial System in Japan (IP-related case)

Topic 5-7. Effective utilization of Patent Classification Systems

Patent examination procedure of Mongolia

Innovation Office. Intellectual Property at the Nelson Mandela University: A Brief Introduction. Creating value for tomorrow

Subregional Seminar on the Legal Protection of Biotechnology and Genetic Resources Banska Bystrica, May 2 and 3, Access and Benefit Sharing

WIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation

Patents. What is a patent? What is the United States Patent and Trademark Office (USPTO)? What types of patents are available in the United States?

B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:

Outline 3/16/2018. Patent Basics for Inventors, Entrepreneurs, and Start-ups.

Why patents DO matter to YOUR business

EAC. The East African Community EAC IRC Repository EAC

US-ANDEAN FREE TRADE AGREEMENT IMPACT ON ACCESS TO MEDICINES AND HEALTH IN COLOMBIA

Intellectual Property

Issues and Possible Reforms in the U.S. Patent System

PROTECTION OF INTELLECTUAL PROPERTY

Technology Commercialization Primer: Understanding the Basics. Leza Besemann

Questionnaire May Q178 Scope of Patent Protection. Answer of the French Group

INVENTION LAW OF THE DEMOCRATIC PEOPLE S REPUBLIC OF KOREA. Chapter 1 Fundamentals

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

What s in the Spec.?

Patent Basics for Inventors, Entrepreneurs, and Start-ups. Ned Landrum Patent Training Advisor STEPP Program Manager

Transcription:

REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 7: Flexibilities Related to the Definition of Patentable Subject Matter Durban, South Africa January 29 to 31, 2013

Flexibilities Related to the Definition of Patentable Subject Matter Presented at Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities 29-31 January, 2013 Durban, South Africa Justine Tambatamba Chilambwe

Outline Of Presentation Introduction The Patent Act Cap. 401 Patentable Subject Matter Exclusions (from Patentability) The Proposed Patent Bill conclusion

: The Patent Act Patent protection in Zambia is governed by the Patents Act Cap. 401 of the laws. The Period of protection is 16 years Patentability is Zambia is based on: Novelty Inventive Step Industrial Applicability Modification or improvement on an existing Patent Section 31

Patentability Criteria TRIPS: Art 27.1: Invention has to be new,, involve inventive step and be capable of industrial applicability Broad definition for novelty leaving room for members states to define novelty in their laws High standards on inventive step encourages member states to grant strong patent Strict concept of industrial applicability prevent monopolies on research tools and basic research

Patentability Criteria cont d Patent Act Cap 401 of the laws of Zambia Novelty / prior art: Known, worked or used in the territory Including in non-public patent files Any publication of which a copy exist in territories With respect to New Use Patents : : Section. 18 (c) : Excluded from patentability: If the invention is a food or medicine and only a mixture of known ingredients

Patentability Criteria cont d Proposed Patent Bill in Zambia Is clear and specific: Prior art: everything disclosed to the public anywhere in the world by publication in tangible form or by oral disclosure Make specific reference to: Inventive Step and industrial applicability are basic requirement for new use patents Traditional knowledge and Genetic Resources used to derive patents

Patentability Criteria cont d Patent Act Cap 401 Inventive Step Invention has to be non-obvious obvious Proposed Bill: Has specific criteria for inventive step or non- obviousness: any invention that any person who is skilled in the art could derive from prior art (one piece of prior art or a combination of different pieces thereof) is obvious with respect to pharmaceutical field: new dosage, combinations, compositions, etc. that have close chemical compositions to prior art cannot be considered as non- obvious

Exclusion from Patent Protection TRIPS provides flexibilities through: Patentability criteria Art. 27.3: a) diagnostic, therapeutic and surgical methods b) plants and animals other than micro-organisms organisms Patent Act Cap 401: Section 18: excludes based on: a) Frivolous grounds b) Against morality c) If the invention is a food or medicine and only a mixture of known ingredients + (discoveries / theories / animals and plant varieties / diagnostic, therapeutic methods for treatment of humans & animals)

Exclusion from Patent Protection cont d Proposed Patent Bill: The Proposed Patent Bill is very precise on this matter: The following are excluded therapeutic and surgical methods biologically occurring plants and animals, Basic research etc. Has transitional period on pharmaceuticals Patent until 2016.

TRIPS General Exceptions Art. 30 allows for limited exceptions Three exceptions with regard to public health: Prior use: prior (secret) users can continue Experimental use: allows for research to be carried out with respect to invention under patent allows for timely launch of specialized drugs Bolar exemption: to seek marketing approval before patent expired allows for timely entry of generic into market

General Exceptions The Patent Act Cap 401: None of the three exceptions exist in Zambian Patent Act Proposed Patent Bill: Prior use: prior (secret) users can continue to do so Experimental use: allows for research to be carried out with respect to invention under patent allows for timely launch of specialized drugs Six months exhibition clause (if exhibition was not for commercial purposes)

Non-voluntary licenses TRIPS Art 31: allows government to issue license without patent holder consent. Does not define the grounds for issuance of license WHO study lists seven state practices: refusal to license public interest public health and nutrition national emergency or situations of extreme urgency; anti competitive practices; dependent patents; failure to exploit or insufficient working.

Non-voluntary licenses Patent Act Cap. 401 6 of 7 state practices exist in the Zambian Patent Act Section 37 allows third parties to apply for CL, if: Unable to obtain a license under reasonable terms After 3 years of filing (four years application) Applicant has to inform patent holder Has to provide appropriate compensation (defined by High Court) Patent holder has right to appeal

Non-voluntary Licenses Grounds for use of Section 37: lack of local working, lack of sufficient domestic supply (through import or local working), if a patent prejudices trade and industry in Zambia unfair conditions attached by the patentee and the abuse of monopoly rights

Non-voluntary licenses Section. 38: Food and medicine products High Court should order license if application by any person interested is made (unless believes there are good reasons for refusing application): For inventions that can be used in food or medicine or production thereof a process for producing such a substance as aforesaid; Any invention that can be used as surgical / curative advice No three (four) year grace period

Non-voluntary licenses Section. 40 Government Use: Very wide spectrum Minister may allow any government department to make use of patented invention Government Use includes supply to other countries for defence purposes Government has to inform patent holder as soon as practicable Can agree on terms after license issued No three (four) year period

Non-voluntary licenses Section. 41 Government Use in Emergency Minister has to declare period of emergency by statutory notice among other for: - maintenance of supplies and services essential to community - for promoting the productivity of industry, commerce and agriculture; - for redressing the balance of trade; - for assisting the relief of suffering and the restoration and distribution of essential supplies and services in any part of Her H Britannic Majesty's dominions or any foreign countries that are in grave distress as the result of war Three (four) year grace period does not apply Patent holder has right to appeal (Art. 42)

Parallel Import TRIPS: Art 6: Members are allowed to define own exhaustion regime Three exhaustion regimes are possible: International Regional National

Parallel Import Patent Act Cap. 401 No provisions included in the statute Proposed Patent Bill: International Regional National

Patent Term and Patent Term TRIPS 20 years ARIPO Extension 20 years (Section 3.10)

: Patent Term and Patent Term Patent Act Cap 401: Extension 16 years (Section. 29) Allows for patent term extensions (Section. 30) of five years (ten in exceptional circumstances), if: Patent holder has not received adequate remuneration Due to hostilities or other special circumstances he suffered loss or damages Proposed Patent Bill patent term to 20 years No patent term extension

Conclusion Zambia realized that most the provisions in the Patent Act Cap. 401 fall short of the requirements of the TRIPS Agreement. In the proposed Patent Amendment Bill Zambia has taken on board the minimum requirements on Patentability in accordance with Article 27 of the TRIPS Agreement. The Proposed Patent Bill is before Parliament and will be passed for enactment soon. Zambia has also taken on board the exclusions as provided by Article 27(3)(a) of TRIPS

The End Thank you!!!!

Contact Details Justine Tambatamba Chilambwe Examiner Patents And Companies Registration Agency (PACRA) Email: j.chilambwe@pacra.org.zm j_t_chilambwe@yahoo.com Cell: +260 211 255 127 Office: Ext: 118